Gold
@Gold_Neuro
Followers
370
Following
528
Media
46
Statuses
1K
Interested in the role of brain-immune networks in human CNS disorders. And other interesting things. Views my own.
Joined March 2018
RT @ErametProject: š What if the next breakthrough medicine is already on the shelf? š .Faster, cheaper treatments through drug repurposingā¦.
0
2
0
RT @doctorveera: The human genome is littered with pleiotropic variants with conflicting effects on disease traits, for e.g., increase theā¦.
0
27
0
RT @ancientstristan: The ^ episode has already proven incredibly popular. Following hot on the heels of a wonderful chat with @ChrisStringeā¦.
0
7
0
RT @MitoPsychoBio: Aging is an energetic process. But how and where do cellular and whole-body energy demands and availability interact?. Tā¦.
0
84
0
RT @MichaelOkun: Can memantine and/or trazadone slow ALS progression? Nope. A brand new large randomized study out by Pal and colleagues @Tā¦.
0
13
0
RT @SciImmunology: Science #Immunology's October issue is out!. This month's cover highlights how #NFkB signaling helps recruit the noncodiā¦.
0
30
0
RT @mirandarwolpert: Proud to be part of the coalition for mental health investment. find out how you can get involved. .
mentalhealthinvestment.org
0
12
0
RT @ECTRIMS: šļø In case you missed it, listen to Prof. Alan Thompson from @UCL wrap up #ECTRIMS2024 and dive into all things ECTRIMS with hā¦.
0
1
0
RT @JAMANeuro: Meta-analysis of 17 phase 3 MS DMT trials shows higher comorbidity burden is associated with increased risk of relapse and dā¦.
0
3
0
RT @bart_professor: Kowalec (US) effect of genetic predisposition for depression on disease activity in #MS. Higher risk of relapse and EDSā¦.
0
3
0
RT @bart_professor: Chataway (UK): MS-stat2 study on simvastatin 80mg vs placebo in SPMS. Large phase 3 trial, unfortunately no significantā¦.
0
4
0
RT @mssociety: #ECTRIMS2024: Society fellow Dr. Amber Salter (Dallas, TX) - Data from 16,794 MS trial participants shows that comorbid (coeā¦.
0
2
0
RT @NaudetFlorian: Ā«Ā Mega-trials (MG) need to be performed more often, given the relative low number of MG found, their low significant raā¦.
jamanetwork.com
This meta-analysis compares results of mega-trials with results from meta-analyses of smaller trials for the primary outcome and all-cause mortality.
0
9
0
RT @Nature: The symptoms of depression might come and go, but new evidence suggests that the pattern of brain wiring behind it remains theā¦.
0
109
0
RT @ADAlthousePhD: @mattyglesias @_alexa_blue In good faith, then, I would like to use this opportunity to help you (and any others!) learnā¦.
0
15
0
RT @BrodinPetter: New paper out @Nature - why are males more vulnerable to severe infections (ex acute #COVID), while females suffer more fā¦.
0
330
0
RT @ScienceMagazine: A new #ScienceReview compares and contrasts the processes involved in traditional randomized clinical trials and newerā¦.
0
23
0
RT @ManojDoss: Didnāt think I could top my last NYT quote, but I think I might have done it with this one š.https:/ā¦.
0
2
0
RT @ARUK_SusanK: A fantastic interview with @UKDRI @TSpiresJones. Very balanced and well worth a listen š.
0
3
0
RT @dr_appie: "For schizophrenia, the chance of getting a diagnosis is ~40% if a genetic clone (an identical twin) is also affected". My shā¦.
0
35
0